Le Lézard
Classified in: Business
Subject: ATY

VRX Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors



BOSTON, Oct. 5, 2017 /PRNewswire/ -- Kyros Law Offices is alerting investors of Valeant Pharmaceuticals Intl (NYSE: VRX)  that it is investigating legal claims against the company for possible securities fraud violations committed by Valeant Pharmaceuticals Intl (NYSE: VRX).

Valeant Pharmaceuticals Intl (NYSE: VRX)  investors that have invested over $100,000 before March 2016 are urged to contact our law firm immediately to protect their rights. Visit our VRX Lawsuit website or call 1-800-934-2921 to speak to someone about your case.

The investigation concerns possible violations of securities law committed by Valeant Pharmaceuticals Intl (NYSE: VRX)  management that has led to significant losses to investors. Recent lawsuits filed against the company allege that Valeant Pharmaceuticals Intl (NYSE: VRX)  may have improperly used a pharmacy network to artificially increase sales for their drugs.

In February 2016, Valeant Pharmaceuticals Intl (NYSE: VRX) announced it would restate its financial results, citing issues with revenue recognition stemming from sales from a specific pharmacy network. That same month, the company came under SEC investigation. During this time, the stock price of VRX dropped significantly, with the share prices dropping more than 90%.

Kyros Law has been recently contacted by numerous unhappy VRX investors with hundreds of thousands of dollars invested in the company. The law firm is dedicated to fighting for the rights of these investors, and other investors that have lost money in VRX stock.

Kyros Law Offices urges Valeant Pharmaceuticals Intl (NYSE: VRX)  investors that invested more than $100,000 prior to March 2016 to contact our law firm immediately to protect their rights. Visit our VRX Lawsuit website or call 1-800-934-2921 to find out if you have a case.

Kyros Law specializes in a wide range of complex litigation, mass torts, and corporate governance matters, including the representation of whistleblowers, shareholders and consumers in securities fraud, false claims act and class actions. Our lawyers have been responsible for recovering hundreds of millions of dollars for our clients throughout the United States, Africa, Asia and Europe. Visit our website to learn more about our firm.

SOURCE Kyros Law


These press releases may also interest you

at 04:00
MarketStar, the industry leader in outsourced sales and marketing, today announced that it is publishing a guide to help AdTech and digital media businesses sell their solutions in the current booming market. The e-book, How Businesses Can Stay...

at 04:00
Agilitas, a pan-European private equity firm, today announces the buyout of Hydro International Limited ("Hydro" or the "Company"), a leading global provider of advanced products, services and technology for the treatment of wastewater and the...

at 03:55
CSA Global recently announced an investment in, and partnership with industry-leading geophysical consulting group Southern Geoscience Consultants (SGC). The investment and partnership align with CSA Global's strategy to diversify and broaden the...

at 03:03
Open Road Alliance, a philanthropic initiative that seeks to preserve impact in the social sector, today announced the launch of Open Road Ventures, a new fund that will disburse at least $50 million in loans to nonprofits and social enterprises over...

at 03:00
MOUNTAIN VIEW, Calif., Feb. 21, 2018 /PRNewswire-PRWeb/ -- Guardian Analytics, the market leader in real-time behavioral analytics and machine learning solutions for banking payment fraud detection, enterprise B2B portal fraud, together with Fintel,...

at 03:00
Biohaven Pharmaceutical Holding Company Ltd. ("Biohaven" or the "Company") announced today that it has entered into an exclusive worldwide license agreement with Catalent U.K. Swindon Zydis Limited, a subsidiary of Catalent, Inc. ("Catalent") to...




News published on 5 october 2017 at 19:46 and distributed by: